
TransMedics ups revenue guidance on strength of its organ transport tech
TransMedics (Nasdaq: TMDX) is starting the year with a strong quarter. The Andover, Massachusetts–based medtech company, which offers an organ care system (OCS) for transplant therapy, hit $143.5 million in revenue for the first quarter, up 48% year over …